Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Multiple Sclerosis Drugs Market Size is projected $34 b

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Mar 15, 2023 10:44am

52 Views

Post# 35339697

RE:Multiple Sclerosis Drugs Market Size is projected $34 b

And FSD is no where close to seeing any of that money.....thta's what happens when the company is mismanaged and it sole purpose is to enrich the BoD and management as peoven by their actions....not to mention that they do not have enough money to complete any of the trials.....got that Rosenberg..."COMPLETE"....not start.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project